Home » Topics » Conferences

Conferences
RSS

Fujsawa selects adenosine A1 receptor antagonist for development

April 11, 1997

MDR-reversing agents described by Nikken Chemicals

April 11, 1997

New LTD4 antagonist from Fujisawa

April 10, 1997

New carbamate derivative from Kyorin with high affinity/selectivity for M1 receptors

April 10, 1997

Senju describes new calpain inhibitor

April 10, 1997

FR-138104: a new D2 antagonist from Fujisawa

April 10, 1997

New bradykinin B2 antagonist from Fujisawa

April 10, 1997

Nigella sativa plant extract exerts antiangiogenic activity

April 8, 1997

PEG-rHuMGDF safe and effective for chemotherapy-induced thrombocytopenia

April 8, 1997

Perindopril accelerates endothelial regrowth in animal model

April 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...